A 35-year-old male farmer from rural Maharashtra presents with a 6-week history of progressive scaling and erythema on both feet, starting from the interdigital spaces and spreading to the soles. He reports intense itching, especially in the evening. On examination, he has maceration and fissuring between the toes with a scaly, erythematous patch on the sole. Fungal culture on Sabouraud medium shows a white colony with a red/purple reverse. What is the most appropriate first-line treatment?

Explanation

## Diagnosis: Tinea Pedis (Athlete's Foot) ### Clinical Presentation **Key Point:** Tinea pedis classically presents with maceration and fissuring in the interdigital spaces (especially between the 4th and 5th toes), with scaling extending to the sole. The intense itching and 6-week duration are typical. ### Mycological Identification **High-Yield:** The white colony with red/purple reverse on Sabouraud medium is pathognomonic for *Trichophyton rubrum*, the most common cause of tinea pedis. ### Treatment Algorithm ```mermaid flowchart TD A[Tinea Pedis Confirmed]:::outcome --> B{Extent of involvement?}:::decision B -->|Interdigital/sole only| C[Topical antifungal]:::action B -->|Extensive/nail involvement| D[Oral antifungal]:::action C --> E[Azole or Allylamine]:::action E --> F[4-6 weeks duration]:::action D --> G[Terbinafine or Griseofulvin]:::action G --> H[6-12 weeks duration]:::action F --> I[Clinical cure]:::outcome H --> I ``` ### First-Line Treatment: Topical Miconazole **Clinical Pearl:** For localized tinea pedis without nail involvement, topical antifungals are the standard first-line therapy. They are effective, have minimal systemic absorption, and avoid drug interactions. ### Topical Antifungal Comparison | Agent | Class | Frequency | Duration | Efficacy | Cost | |-------|-------|-----------|----------|----------|------| | **Miconazole** | Imidazole | Twice daily | 4 weeks | Excellent | Low | | **Clotrimazole** | Imidazole | Twice daily | 4 weeks | Excellent | Low | | **Terbinafine** | Allylamine | Once daily | 2–4 weeks | Excellent | Moderate | | **Tolnaftate** | Thiocarbamate | Twice daily | 2–4 weeks | Moderate | Low | **Why Miconazole?** - Broad-spectrum imidazole with activity against dermatophytes, yeasts, and some gram-positive bacteria - Topical application achieves high local concentration in the stratum corneum - Minimal systemic absorption (< 1%) - No drug interactions - Cost-effective - 4-week course is standard for tinea pedis ### Why NOT the Other Options? **Oral Terbinafine (250 mg daily for 6 weeks):** - Indicated for nail involvement (onychomycosis) or extensive/recurrent disease - Overkill for localized interdigital/sole tinea pedis - Higher cost, systemic side effects (hepatotoxicity, taste disturbance), drug interactions - Unnecessarily prolonged for non-ungual disease **Oral Griseofulvin (500 mg daily for 8 weeks):** - Older agent, less effective than terbinafine for dermatophytes - Requires fatty meal for absorption - Longer duration needed (8 weeks vs. 6 weeks for terbinafine) - Not first-line for tinea pedis - Higher relapse rates **Topical Tolnaftate (twice daily for 2 weeks):** - Thiocarbamate with fungistatic activity only (does not kill fungus) - Inferior efficacy compared to azoles and allylamines - 2-week duration is too short for tinea pedis (standard is 4 weeks) - Higher relapse rates - Not recommended for active dermatophyte infection **High-Yield:** **Topical azoles (miconazole, clotrimazole) or allylamines (terbinafine) for 4 weeks = standard first-line for localized tinea pedis. Oral agents reserved for nail involvement or extensive disease.** **Mnemonic:** **TOES = Topical for Obvious Early Superficial** tinea pedis without nails.